(0.37%) 5 110.25 points
(0.79%) 38 685 points
(0.64%) 17 763 points
(-0.10%) $78.87
(-0.34%) $2.03
(0.02%) $2 310.00
(-0.09%) $26.81
(1.71%) $979.10
(-0.15%) $0.931
(-0.68%) $10.92
(-0.20%) $0.796
(0.43%) $91.52
-0.53% $ 200.25
Live Chart Being Loaded With Signals
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions...
Stats | |
---|---|
Tagesvolumen | 500 028 |
Durchschnittsvolumen | 799 177 |
Marktkapitalisierung | 16.84B |
EPS | $0 ( 2024-04-25 ) |
Nächstes Ertragsdatum | ( $3.80 ) 2024-07-25 |
Last Dividend | $0.720 ( 2023-11-07 ) |
Next Dividend | $0 ( N/A ) |
P/E | 42.88 |
ATR14 | $0.0910 (0.05%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-30 | Anderson Kerrii B | Sell | 250 | Common Stock |
2024-05-02 | Anderson Kerrii B | Sell | 250 | Common Stock |
2024-04-30 | Eisenberg Glenn A | Buy | 10 229 | Common Stock |
2024-04-30 | Eisenberg Glenn A | Sell | 4 496 | Common Stock |
2024-04-30 | Eisenberg Glenn A | Sell | 10 229 | Performance Share Unit |
INSIDER POWER |
---|
-11.09 |
Last 100 transactions |
Buy: 259 185 | Sell: 319 041 |
Volumen Korrelation
Laboratory Corporation of Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Laboratory Corporation of Korrelation - Währung/Rohstoff
Laboratory Corporation of Finanzdaten
Annual | 2023 |
Umsatz: | $12.16B |
Bruttogewinn: | $3.15B (25.86 %) |
EPS: | $4.80 |
FY | 2023 |
Umsatz: | $12.16B |
Bruttogewinn: | $3.15B (25.86 %) |
EPS: | $4.80 |
FY | 2022 |
Umsatz: | $14.88B |
Bruttogewinn: | $4.39B (29.48 %) |
EPS: | $14.04 |
FY | 2021 |
Umsatz: | $16.12B |
Bruttogewinn: | $5.62B (34.89 %) |
EPS: | $24.60 |
Financial Reports:
No articles found.
Laboratory Corporation of Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.720 (N/A) |
$0.720 (N/A) |
$0.720 (N/A) |
$0.720 (N/A) |
$0.720 (N/A) |
$0.720 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.150 | 1990-12-31 |
Last Dividend | $0.720 | 2023-11-07 |
Next Dividend | $0 | N/A |
Payout Date | 2023-12-12 | |
Next Payout Date | N/A | |
# dividends | 21 | -- |
Total Paid Out | $7.64 | -- |
Avg. Dividend % Per Year | 0.54% | -- |
Score | 2.73 | -- |
Div. Sustainability Score | 8.88 | |
Div.Growth Potential Score | 5.15 | |
Div. Directional Score | 7.01 | -- |
Year | Amount | Yield |
---|---|---|
1990 | $0.150 | 0.61% |
1991 | $0.500 | 2.19% |
1992 | $0.950 | 1.59% |
1993 | $0.800 | 2.11% |
1994 | $0.200 | 0.65% |
1995 | $0 | 0.00% |
1996 | $0 | 0.00% |
1997 | $0 | 0.00% |
1998 | $0 | 0.00% |
1999 | $0 | 0.00% |
2000 | $0 | 0.00% |
2001 | $0 | 0.00% |
2002 | $0 | 0.00% |
2003 | $0 | 0.00% |
2004 | $0 | 0.00% |
2005 | $0 | 0.00% |
2006 | $0 | 0.00% |
2007 | $0 | 0.00% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $2.16 | 0.84% |
2023 | $2.88 | 1.41% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
ZTR | Dividend King | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
SCM | Dividend King | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0352 | 1.500 | 9.30 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0262 | 1.200 | 9.13 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0533 | 1.500 | -0.518 | -0.778 | [0.1 - 1] |
payoutRatioTTM | 0.581 | -1.000 | 4.19 | -4.19 | [0 - 1] |
currentRatioTTM | 0.877 | 0.800 | -0.615 | -0.492 | [1 - 3] |
quickRatioTTM | 0.584 | 0.800 | -1.268 | -1.015 | [0.8 - 2.5] |
cashRatioTTM | 0.0252 | 1.500 | -0.971 | -1.457 | [0.2 - 2] |
debtRatioTTM | 0.319 | -1.500 | 4.69 | -7.03 | [0 - 0.6] |
interestCoverageTTM | 5.50 | 1.000 | 9.07 | 9.07 | [3 - 30] |
operatingCashFlowPerShareTTM | 13.99 | 2.00 | 5.34 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 7.95 | 2.00 | 6.03 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.662 | -1.500 | 7.35 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.268 | 1.000 | 8.87 | 8.87 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0875 | 1.000 | -0.249 | -0.249 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.223 | 1.000 | 9.87 | 9.87 | [0.2 - 2] |
assetTurnoverTTM | 0.744 | 0.800 | 8.37 | 6.70 | [0.5 - 2] |
Total Score | 8.88 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 38.88 | 1.000 | 6.17 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0533 | 2.50 | -0.333 | -0.778 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 7.95 | 2.00 | 7.35 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.388 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 13.99 | 2.00 | 5.34 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.581 | 1.500 | 4.19 | -4.19 | [0 - 1] |
pegRatioTTM | 2.26 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0957 | 1.000 | -0.108 | 0 | [0.1 - 0.5] |
Total Score | 5.15 |
Laboratory Corporation of
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.